Aldeyra Therapeutics Announces Achievement of Statistical Si

Statistical Significance Achieved for Primary Endpoint of Ocular Itching at All Prespecified Timepoints



Statistical Significance Achieved for Key Secondary Endpoint of Ocular Redness... | June 15, 2023

Related Keywords

United States , Ptoddc Brady , , Drug Administration New Application , Facebook , Drug Administration New Application Priority , Nasdaq , Aldeyra Therapeutics Inc , Linkedin , Exchange Commission , Twitter , Securities Exchange , Aldeyra Therapeutics , Investor Relations , Drug Administration New Application Review , Private Securities Litigation Reform Act , Securities Exchange Act , Financial Condition , Annual Report , Quarterly Report ,